Circulating tumor DNA (ctDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC).

Authors

null

Sumitra Ananda

Peter MacCallum Cancer Centre, Epworth Healthcare, Western Health, Walter and Eliza Hall Institute, University of Melbourne, Melbourne, VIC, Australia

Sumitra Ananda , Yuxuan Wang , Wei Hong , Gary Edward Richardson , Janine Margaret Lombard , Geraldine Goss , Linda R. Mileshkin , Christopher B. Steer , Anne Marie Lennon , Orla McNally , Christopher B Douville , Maria Popoli , Janine Ptak , Natalie Silliman , Lisa Dobbyn , Nickolas Papadopoulos , Kenneth W. Kinzler , Bert Vogelstein , Jeanne Tie , Peter Gibbs

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

ACTRN12617001119381

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5553)

DOI

10.1200/JCO.2023.41.16_suppl.5553

Abstract #

5553

Poster Bd #

248

Abstract Disclosures

Similar Posters

First Author: Sakti Chakrabarti

First Author: Qingqi Hong

First Author: Abhineet Uppal

First Author: Janet Alvarez